Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Chataway

Showing results (11-20 of 182) with videos related to

Pageof 19
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 6, 2016
Biotin in progressive multiple sclerosis: A new lead?Jeremy Chataway
Journal of Neurology, Neurosurgery, and Psychiatry|April 22, 2020
Distribution of plaques in the cerebrum in multiple sclerosisJeremy Chataway
Journal of Neurology|February 22, 2011
Relapse risk in patients with multiple sclerosis after H1N1 vaccination, with or without seasonal influenza vaccinationNuala McNicholas, Jeremy Chataway
BMJ Clinical Evidence|July 8, 2011
Multiple sclerosisRichard Nicholas, Jeremy Chataway
Clinical Neurology and Neurosurgery|September 6, 2011
The successful long-term management of an intracranial inflammatory myofibroblastic tumor with corticosteroidsChristopher Carswell, Jeremy Chataway
Clinical Medicine (London, England)|December 14, 2016
Multiple sclerosis, a treatable diseaseAnisha Doshi, Jeremy Chataway
Nature Reviews. Neurology|September 22, 2022
Beyond ocrelizumab in primary progressive multiple sclerosisThomas Williams, Jeremy Chataway
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 4, 2018
Immune-mediated encephalitis with daclizumab: The final nailThomas Williams, Jeremy Chataway
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 4, 2016
The N-MOmentum trial: Building momentum to advance trial methodology in a rare diseaseJeremy Chataway, Tim Friede
Clinical Medicine (London, England)|December 3, 2017
Multiple sclerosis, a treatable disease Anisha Doshi, Jeremy Chataway
Pageof 19

Showing results (11-20 of 182) with videos related to

Sort By:
Pageof 19
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 6, 2016
Biotin in progressive multiple sclerosis: A new lead?Jeremy Chataway
Journal of Neurology, Neurosurgery, and Psychiatry|April 22, 2020
Distribution of plaques in the cerebrum in multiple sclerosisJeremy Chataway
Journal of Neurology|February 22, 2011
Relapse risk in patients with multiple sclerosis after H1N1 vaccination, with or without seasonal influenza vaccinationNuala McNicholas, Jeremy Chataway
BMJ Clinical Evidence|July 8, 2011
Multiple sclerosisRichard Nicholas, Jeremy Chataway
Clinical Neurology and Neurosurgery|September 6, 2011
The successful long-term management of an intracranial inflammatory myofibroblastic tumor with corticosteroidsChristopher Carswell, Jeremy Chataway
Clinical Medicine (London, England)|December 14, 2016
Multiple sclerosis, a treatable diseaseAnisha Doshi, Jeremy Chataway
Nature Reviews. Neurology|September 22, 2022
Beyond ocrelizumab in primary progressive multiple sclerosisThomas Williams, Jeremy Chataway
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 4, 2018
Immune-mediated encephalitis with daclizumab: The final nailThomas Williams, Jeremy Chataway
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 4, 2016
The N-MOmentum trial: Building momentum to advance trial methodology in a rare diseaseJeremy Chataway, Tim Friede
Clinical Medicine (London, England)|December 3, 2017
Multiple sclerosis, a treatable disease Anisha Doshi, Jeremy Chataway
Pageof 19